Home › Geographic Atrophy › Texas › McAllen
Geographic Atrophy clinical trials in McAllen, TX
3 studies for Geographic Atrophy are looking for participants at sites in and around McAllen (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RecruitingPhase 1/2
- Valley Retina Institute, PA, McAllen
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Valley Retina Institute, P.A., McAllen
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Valley Retina Institute, P.A., McAllen
Geographic Atrophy trials in other cities
- Dallas, TX8 studies
- Reno, NV8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Cleveland, OH6 studies
- Houston, TX6 studies
- The Woodlands, TX6 studies
- Naperville, IL6 studies
- Baltimore, MD6 studies
- Spokane, WA5 studies
- Erie, PA5 studies
- Washington, DC5 studies
Other studies in McAllen
- Macular Degeneration6 studies
- Metastatic Cancer5 studies
- Breast Cancer4 studies
- Atherosclerosis4 studies
- Heart Failure3 studies
- Obesity3 studies
- Cardiovascular Disease3 studies
- Diabetic Foot3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.